Planegg/Martinsried, April 25, 2024. Medigene AG , an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today presents a.
12.06.2023 - LONDON, June 12, 2023 (GLOBE NEWSWIRE) - Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies to treat solid tumors, today announced that the Company will be taking .
LONDON, UK / ACCESSWIRE / May 16, 2022 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce its participation in the Immuno-Oncology Summit Europe 2022, at which Dr Vladislav Sandler will